Regulatory consideration on preparation and clinical use of COVID-19 convalescent plasma

S Yılmaz, NE Örüç, Oİ Özcebe, A Azap, AT Çetin… - … and Apheresis Science, 2020 - Elsevier
Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the cause of
coronavirus disease (COVID-19), spreading from Wuhan to worldwide has been emerged …

COVID 19 convalescent plasma: Is there still a place for CCP?

R Moog - Transfusion and Apheresis Science, 2023 - Elsevier
Background Convalescent plasma has been used for a long time for the treatment of various
infectious diseases. The principle is to collect antibody-containing plasma from recovered …

Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study

H Abolghasemi, P Eshghi, AM Cheraghali… - … and Apheresis Science, 2020 - Elsevier
Since Dec. 2019 the new coronavirus (SARS-CoV-2) has infected millions and claimed life
of several hundred thousand worldwide. However, so far no approved vaccine or drug …

COVID-19 convalescent plasma therapy: Analyzing the factors that led to its failure in India

N Bansal, M Raturi, Y Bansal - Transfusion Clinique et Biologique, 2021 - Elsevier
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) resulted in a global pandemic in early 2020. Various …

International forum on the collection and use of COVID‐19 convalescent plasma: protocols, challenges and lessons learned: summary

AZ Al‐Riyami, T Burnouf, M Yazer, D Triulzi… - Vox …, 2021 - Wiley Online Library
Coronavirus disease-2019 (COVID-19), caused by severe acute respiratory coronavirus 2
(SARS-CoV-2), has rapidly spread since its first declaration by the World Health …

Effectiveness of COVID-19 convalescent plasma (CCP) during the pandemic era: a literature review

UR Kandula, TS Tuji, DB Gudeta… - Journal of Blood …, 2023 - Taylor & Francis
Worldwide pandemic with coronavirus disease-2019 (COVID-19) was caused by severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2). As November 2, 2022, World …

[HTML][HTML] The application of COVID-19 convalescent plasma in clinical treatment

Y Liu, A Liu, R Wang, C Shao, P Li, Q Ju… - Annals of …, 2022 - aob.amegroups.org
The severe acute respiratory syndrome (SARS) coronavirus disease known as coronavirus
disease 2019 (COVID-19), which is caused by SARS-CoV-2 has caused a global pandemic …

Anti-SARS-CoV-2 hyperimmune plasma workflow

P Annamaria, Q Eugenia, S Paolo - Transfusion and Apheresis Science, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) caused by the novel coronavirus has
become a Public Health Emergency of International Concern. Among the various treatment …

Google Trends demonstrate public interest in COVID‐19 convalescent plasma therapy.

BD Adkins, GS Booth - Journal of Clinical Apheresis, 2021 - search.ebscohost.com
Abstract DATA AVAILABILITY STATEMENT The data that support the findings of this study
are openly available in Google Trends. Google Trends demonstrate public interest in COVID …

Clinical use of Convalescent Plasma in the COVID‐19 pandemic: a transfusion‐focussed gap analysis with recommendations for future research priorities

AZ Al‐Riyami, R Schäfer, K van Den Berg… - Vox …, 2021 - Wiley Online Library
Background and objectives Use of convalescent plasma for coronavirus disease 2019
(COVID‐19) treatment has gained interest worldwide. However, there is lack of evidence on …